This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: The Ohio State University, The University of Tennessee Research Foundation. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2007-2010
Title: Veeresa Gududuru: Innovator in Cancer Treatment
Introduction
Veeresa Gududuru is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. With a total of 2 patents, his work focuses on creating selective anti-cancer agents.
Latest Patents
Gududuru's latest patents include groundbreaking compounds such as thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides. These compounds are designed as selective anti-cancer agents, with methods of making these compounds and their pharmaceutical compositions disclosed. His patents detail the use of substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides, where various substituent groups are defined in the specification. The methods outlined in his patents emphasize their potential for treating or preventing cancer.
Career Highlights
Throughout his career, Gududuru has worked with esteemed institutions such as the University of Tennessee Research Foundation and The Ohio State University. His research has been pivotal in advancing the understanding and treatment of cancer through innovative pharmaceutical solutions.
Collaborations
Some of his notable coworkers include Duane Douglas Miller and James T Dalton. Their collaborative efforts have contributed to the success of Gududuru's research and the development of his patented compounds.
Conclusion
Veeresa Gududuru stands out as an influential inventor in the realm of cancer treatment. His innovative patents and collaborations with leading research institutions highlight his commitment to advancing medical science. His work continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile